Financials
Financial year 2026
Medisto from Tervuren, company number BE0508921089, closed financial year 2026 with a result of € -7,900 after tax. For that financial year Medisto recorded a gross margin of € -3,856 and equity of € 26,205. Compared with financial year 2025, the result moved from € 3,492 to € -7,900. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on October 27, 2026.
€ 26,205
▼ 23% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -7,900
▼ still € 3,492 profit in 2025
Profit after tax over the fiscal year.
€ 34,686
▼ 12% vs 2025
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 20,005.
Debts at end 2026
€ 75,000
Loans from banks and other lenders, long and short.
€ 18,607
▲ 92% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 6,102
▲ 5% vs 2025
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € -24,395 | € 10,861 | € 9,002 | € -3,856 | ▼ € 12,858 |
| Profit after taxes | € -15,498 | € -7,840 | € 3,492 | € -7,900 | ▼ € 11,392 |
| Equity | € 38,453 | € 30,613 | € 34,105 | € 26,205 | ▼ 23% |
| Total debts | € 111,421 | € 108,997 | € 106,293 | € 112,423 | ▲ 6% |
| Cash | € 25,399 | € 34,995 | € 39,394 | € 34,686 | ▼ 12% |
| Retained profit | € 32,253 | € 24,413 | € 27,905 | € 20,005 | ▼ 28% |
| Bank debt | € 75,000 | € 75,000 | € 75,000 | € 75,000 | |
| Balance sheet total | € 149,874 | € 139,609 | € 140,398 | € 138,627 | ▼ 1% |
Key figures of Medisto, fiscal years 2022 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to Medisto?
What happened at Medisto in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: loss of € 7,900 (▼ € 11,392 vs 2025). Source: NBB ↗
- New establishment in Tervuren. KBO
- New establishment in Tervuren. KBO
- Michel Stoove became a director. NBB
- Lieselot Leroy became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 15,498 loss in 2022 to € 7,900 loss in 2026.
Paid € 2,475 in corporate taxes since 2022.
Best year ever: 2025, with € 3,492 profit.
Management
Behind Medisto are Michel Stoove and Lieselot Leroy.
Directors
According to the 2026 annual accounts
Michel Stoove
Director
since 2012
Lieselot Leroy
Director
since 2012
Establishments
Establishment units
Physical locations of this company
Duisburgsesteenweg 13
3080 Tervuren
Klarastraat 4
3080 Tervuren
Active since 1 October 2017
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0508.921.089
- VAT number
- BE 0508.921.089
- Registered office
- Duisburgsesteenweg 13, 3080 Tervuren
- Names & denominations
- Medisto
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 December 2012
- Peppol
- Active · Active since 21 Oct 2026
- Activities · NACE
Detailhandel in kledingstoffen
Computerinfrastructuur, gegevensverwerking, hosting en aanverwante activiteiten
Prepress- en premediadiensten
Ontwerpen van computerprogramma’s
Niet-gespecialiseerde groothandel
Detailhandel in huishoudtextiel en beddengoed
Detailhandel in overig textiel
Detailhandel in dames-, heren-, baby- en kinderboven- en onderkleding en kledingaccessoires (algemeen assortiment)
+4